Biologics Commonly Used in Cutaneous Crohn's Disease - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

  • By

  • Andrea Surnit

  • May 27, 2026

  • 3 min

Share

  • 1

    A retrospective study found that most patients with cutaneous Crohn disease improved after receiving biologic or small-molecule inhibitor therapy.

  • 2

    The study reviewed data from 57 patients, with 81% being female and a mean diagnosis age of 37 years.

  • 3

    Genital involvement was the most common cutaneous presentation, occurring in 44% of patients.

  • 4

    Tumor necrosis factor alpha inhibitors were the most frequently prescribed biologics, used in 85% of treated patients.

  • 5

    The study's limitations include its uncontrolled design and variability in treatment regimens across institutions.

Original Source(s)

Biologics Commonly Used in Cutaneous Crohn's Disease

  • by Andrea Surnit

  • May 27, 2026

Related Content

Anti-CD146 Linked to Silica in Systemic Sclerosis

Comparative analysis across exposed workers, cancer controls, and healthy donors supports specificity.

Psychological impact and quality of life in pediatric patients with chronic skin disorders: a systematic review (2010–2025)

A Systematic Review of Electrochemotherapy Applications in Pediatric Patients